1. Home
  2. ATR vs CYTK Comparison

ATR vs CYTK Comparison

Compare ATR & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AptarGroup Inc.

ATR

AptarGroup Inc.

HOLD

Current Price

$121.37

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$66.52

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATR
CYTK
Founded
1992
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.6B
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
ATR
CYTK
Price
$121.37
$66.52
Analyst Decision
Buy
Strong Buy
Analyst Count
4
19
Target Price
$170.25
$89.26
AVG Volume (30 Days)
401.2K
1.5M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.56%
N/A
EPS Growth
6.51
N/A
EPS
1.12
N/A
Revenue
$3,777,181,000.00
$13,368,000.00
Revenue This Year
$5.18
$7.37
Revenue Next Year
$4.98
$310.19
P/E Ratio
$108.06
N/A
Revenue Growth
5.42
N/A
52 Week Low
$103.23
$29.31
52 Week High
$164.28
$70.98

Technical Indicators

Market Signals
Indicator
ATR
CYTK
Relative Strength Index (RSI) 39.81 56.82
Support Level $118.91 $59.12
Resistance Level $125.35 $70.23
Average True Range (ATR) 3.81 2.56
MACD -0.64 -0.12
Stochastic Oscillator 27.32 91.29

Price Performance

Historical Comparison
ATR
CYTK

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: